An Integrative Clinical Model for the Prediction of Pathological Complete Response in Patients with Operable Stage II and Stage III Triple-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy. Cancers (Basel). 2022 Aug 28;14(17):4170. doi: 10.3390/cancers14174170. Wai-Shan Chung , Shin-Cheh Chen , Tai-Ming Ko , Yung-Chang Lin, Sheng-Hsuan Lin , Yung-Feng Lo , Shu-Chi Tseng , Chi-Chang Yu*.
FACTORS AFECTING LOCOREGIONAL RECURRENCE IN BREAST CANCER PATIENTS UNDERGOING SURGERY FOLLOWING NEOADJUVANT TREATMENT BMC SURGERY 2021 Chung WS, Chou HH*, Ding RY, Kuo WL, Yu CC, Tsai HP, Shen SC, Chu CH, Lo YF, Chen SC.
